Arcus Biosciences, Inc. (RCUS)

Healthcare · Biotechnology · NYSE

Arcus Biosciences, Inc. (RCUS) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $3.60B and a free-cash-flow yield of -15.8%. Over the most recent reported fiscal year, revenue declined 4.3%.

Market cap	$3.60B
Trailing P/E	—
FCF yield	-15.8%
Revenue growth (YoY)	-4.3%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NYSE
Sector	Healthcare
Industry	Biotechnology

Explore live RCUS data on Nama Insights →